The chip can simulate breathing and lung disease for an individual, holding promise for testing personalized treatments for tuberculosis.
FibroBiologics submits IND application with US FDA to initiate clinical trials of CYPS317 in psoriasis patients: Houston Saturday, January 3, 2026, 11:00 Hrs [IST] FibroBiologics ...
The World Health Organization (WHO) has published its new 2025 Guidelines on the replacement or removal of animal tests for ...
Pea-size clusters of human cells called brain organoids inspire both hope and fear. Experts are debating how scientists can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback